Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02969525
Brief Title: A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis (BE ACTIVE)

First Submitted : November 10, 2016
First Submitted that Met QC Criteria : November 16, 2016
First Posted : November 21, 2016 (Estimate)

Results First Submitted : October 30, 2020
Results First Submitted that Met QC Criteria : October 30, 2020
Results First Posted : November 25, 2020

Certification/Extension First Submitted : November 2, 2018
Certification/Extension First Submitted that Met QC Criteria : November 2, 2018
Certification/Extension First Posted : November 6, 2018

Last Update Submitted that Met QC Criteria : October 30, 2020
Last Update Posted : November 25, 2020